, Tracking Stock Market Picks
Enter Symbol:
Ptc Therapeutics Inc. (PTCT) [hlAlert]

up 132.25 %

Ptc Therapeutics Inc. (PTCT) rated Outperform by Credit Suisse

Posted on: Monday,  Jul 15, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Ptc Therapeutics Inc. (NASDAQ: PTCT) on 07/15/2013, when the stock price was $17.70. Since
then, Ptc Therapeutics Inc. has gained 132.26% as of 01/08/2016's recent price of $41.11.
If you would have followed this Credit Suisse's recommendation on PTCT, you would have gained 132.25% of your investment in 907 days.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/15/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  2.16 %
1 Month up  4.10 %
3 Months down  -20.43 %
1 YTD down  -4.06 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy